Medicines Discovery Catapult (MDC) is enabling the community to reshape medicines discovery in the UK. It is ambitious, and it is achievable.
We do this by championing innovative life science technology and new approaches, supporting UK innovators to succeed.
We are helping to industrialise and drive the adoption of new techniques and technologies.
We are driven by helping our community make their mark on the industry and patients.If you’re involved with medicines discovery in the UK, MDC can almost certainly assist you. Our impact is measured by your success.
£13m Translational Research Facility in Infectious Disease to Bolster North West’s Status as International Powerhouse in Life Sciences
The UK’s centre for therapeutics innovation, Medicines Discovery Catapult (MDC), has received a £5 million grant to build a Translational Research Facility in Infectious Disease
Chris Molloy, Chief Executive Officer of the Medicines Discovery Catapult will be stepping down in September 2021 after five years in the role Prof. Chris
Accelerated and more efficient drug discovery in psychiatry – the impetus behind a year of upcoming activity between the Psychiatry Consortium and BNA
Psychiatric drug discovery must be a truly collaborative process if it is to be successful. To enable a more unified approach, we need a better